DE3686019D1 - Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten. - Google Patents
Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten.Info
- Publication number
- DE3686019D1 DE3686019D1 DE8686201789T DE3686019T DE3686019D1 DE 3686019 D1 DE3686019 D1 DE 3686019D1 DE 8686201789 T DE8686201789 T DE 8686201789T DE 3686019 T DE3686019 T DE 3686019T DE 3686019 D1 DE3686019 D1 DE 3686019D1
- Authority
- DE
- Germany
- Prior art keywords
- stomestonal
- nitrofurantoin
- diseases
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/790,919 US4959384A (en) | 1985-10-24 | 1985-10-24 | Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3686019D1 true DE3686019D1 (de) | 1992-08-20 |
DE3686019T2 DE3686019T2 (de) | 1993-01-07 |
Family
ID=25152123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8686201789T Expired - Fee Related DE3686019T2 (de) | 1985-10-24 | 1986-10-15 | Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten. |
Country Status (6)
Country | Link |
---|---|
US (1) | US4959384A (de) |
EP (1) | EP0219912B1 (de) |
JP (1) | JP2669818B2 (de) |
DE (1) | DE3686019T2 (de) |
IE (1) | IE59739B1 (de) |
PH (1) | PH21421A (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3874917T2 (de) * | 1987-03-09 | 1993-03-04 | Procter & Gamble | Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen. |
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
US5178880A (en) * | 1989-07-25 | 1993-01-12 | Norwich Eaton Pharmaceuticals, Inc. | Liquid suspensions of nitrofurantoin |
GB9010039D0 (en) * | 1990-05-03 | 1990-06-27 | Reckitt & Colmann Prod Ltd | Medicament preparation |
GB9120131D0 (en) * | 1991-09-20 | 1991-11-06 | Glaxo Group Ltd | Medicaments |
WO1995008332A1 (en) * | 1993-09-20 | 1995-03-30 | The Procter & Gamble Company | Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection |
US6521270B1 (en) * | 2001-06-11 | 2003-02-18 | The Procter & Gamble Company | Compositions comprising nitrofurantoin and uva ursi |
US7238357B2 (en) * | 2002-11-05 | 2007-07-03 | Allergan, Inc. | Methods for treating ulcers and gastroesophageal reflux disease |
EP1563084A4 (de) * | 2002-11-08 | 2006-03-01 | Hematech Llc | Transgene ungulaten mit reduzierter prionproteinaktivität und verwendungen davon |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3650504T2 (de) * | 1985-06-13 | 1996-10-31 | Marshall Barry James | Verfahren und Zusammensetzungen zur Behandlung von gastrointestinalen Störungen |
-
1985
- 1985-10-24 US US06/790,919 patent/US4959384A/en not_active Expired - Fee Related
-
1986
- 1986-10-15 EP EP86201789A patent/EP0219912B1/de not_active Expired - Lifetime
- 1986-10-15 DE DE8686201789T patent/DE3686019T2/de not_active Expired - Fee Related
- 1986-10-22 PH PH34401A patent/PH21421A/en unknown
- 1986-10-23 IE IE280086A patent/IE59739B1/en not_active IP Right Cessation
- 1986-10-24 JP JP61253553A patent/JP2669818B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0219912A3 (en) | 1989-07-26 |
IE59739B1 (en) | 1994-03-23 |
JP2669818B2 (ja) | 1997-10-29 |
DE3686019T2 (de) | 1993-01-07 |
US4959384A (en) | 1990-09-25 |
JPS62161726A (ja) | 1987-07-17 |
IE862800L (en) | 1987-04-24 |
EP0219912B1 (de) | 1992-07-15 |
PH21421A (en) | 1987-10-15 |
EP0219912A2 (de) | 1987-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3579113D1 (de) | Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. | |
DE3683318D1 (de) | Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege. | |
ATE131068T1 (de) | Behandlung von pathologischen zuständen und krankheiten. | |
DE3583392D1 (de) | Carbonatapatit enthaltendes mittel und die verwendung von carbonatapatit fuer implantate. | |
ATE384703T1 (de) | Piperazinyl-substituierte phenylpyrimidinderivative zur behandlung oder vorbeugung von zns erkrankungen | |
ATE31670T1 (de) | Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material. | |
DE3688296D1 (de) | Arzneimittel zur behandlung von erbrechen. | |
DE3587741D1 (de) | Behandlung von Hautkrankheiten. | |
DE3583220D1 (de) | Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten. | |
DE3782028D1 (de) | Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen. | |
ATE221763T1 (de) | Die verwendung von glyceryltriacetat zur behandlung von onychomykosen | |
DE3781574D1 (de) | Calixaren-derivate und die verwendung dieser verbindungen zur sequestrierung von metallen. | |
DE3686019D1 (de) | Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten. | |
DE3687692D1 (de) | Geschlechtshormone zur behandlung von immun-mangel-krankheiten. | |
DE3687097D1 (de) | Therapeutisches mittel zur behandlung haematopoietischer krankheiten. | |
DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
DE3679781D1 (de) | Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung. | |
DE3586420D1 (de) | Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose. | |
AT383142B (de) | Vorrichtung zur kultivierung und behandlung von biokatalysatoren | |
DE3686688D1 (de) | Verwendung von sulfanilamido quinoxalinen zur behandlung von neoplastischen krankheiten. | |
DE68909750D1 (de) | Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias. | |
ATE136463T1 (de) | Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen | |
DE3688414D1 (de) | Verwendung von chinolinderivaten zur herstellung von medikamenten zur behandlung von zerebralen gefaesskrankheiten und zerebraler senilitaet. | |
DE3881377D1 (de) | Mittel zur prophylaxe und behandlung von thrombocytopenie. | |
DE69103294D1 (de) | Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: PROCTER & GAMBLE PHARMACEUTICALS, NORWICH, N.Y., U |
|
8339 | Ceased/non-payment of the annual fee |